InMed Pharmaceuticals Inc (INM)
5.02
+4.79
(+2060.07%)
USD |
NASDAQ |
Nov 14, 16:00
5.02
0.00 (0.00%)
After-Hours: 20:00
InMed Pharmaceuticals Total Liabilities (Quarterly): 2.617M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 2.617M |
March 31, 2024 | 2.254M |
December 31, 2023 | 2.483M |
September 30, 2023 | 1.339M |
June 30, 2023 | 2.017M |
March 31, 2023 | 2.342M |
December 31, 2022 | 2.585M |
September 30, 2022 | 3.576M |
June 30, 2022 | 3.709M |
March 31, 2022 | 4.599M |
December 31, 2021 | 5.216M |
September 30, 2021 | 2.106M |
June 30, 2021 | 2.405M |
March 31, 2021 | 1.930M |
December 31, 2020 | 4.157M |
September 30, 2020 | 2.110M |
June 30, 2020 | 1.924M |
March 31, 2020 | 1.633M |
December 31, 2019 | 1.564M |
September 30, 2019 | 1.414M |
June 30, 2019 | 1.190M |
March 31, 2019 | 0.5001M |
December 31, 2018 | 0.4039M |
September 30, 2018 | 0.457M |
June 30, 2018 | 0.713M |
Date | Value |
---|---|
March 31, 2018 | 0.4926M |
December 31, 2017 | 0.2358M |
September 30, 2017 | 0.1528M |
June 30, 2017 | 0.2842M |
March 31, 2017 | 0.2473M |
December 31, 2016 | 0.16M |
September 30, 2016 | 0.3155M |
June 30, 2016 | 0.4562M |
March 31, 2016 | 0.649M |
December 31, 2015 | 0.3787M |
September 30, 2015 | 0.1941M |
June 30, 2015 | 0.0625M |
March 31, 2015 | 0.3188M |
December 31, 2014 | 0.4477M |
September 30, 2014 | 0.2409M |
June 30, 2014 | 0.0701M |
March 31, 2014 | 0.1847M |
December 31, 2013 | 0.0931M |
September 30, 2013 | 0.0582M |
June 30, 2013 | 0.0492M |
March 31, 2013 | 0.0329M |
December 31, 2012 | 0.0243M |
September 30, 2012 | 0.0447M |
June 30, 2012 | 0.0446M |
March 31, 2012 | 0.0141M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.339M
Minimum
Sep 2023
5.216M
Maximum
Dec 2021
2.661M
Average
2.342M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
Rimrock Gold Corp | 0.4337M |
CeCors Inc | -- |
Venus Concept Inc | 75.39M |
Aurinia Pharmaceuticals Inc | 161.36M |
Edesa Biotech Inc | 2.361M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.82M |
Shareholders Equity (Quarterly) | 9.206M |
Current Ratio | 4.407 |